BEL 20 at 6,130.41 Points at European Midday
Published on 11/10/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBEL 20 Extends Record-Setting Rally
- The BEL 20 stood at 6,130.41 points at 13:00:30 Berlin time on Tuesday, up 0.53 percent from Monday's close.
- The index opened at 6,122.61 and reached an intraday high of 6,141.13, according to the latest market quote.
- Aperam and KBC were among the leading stocks shortly after the open, while Monday's advance was led by healthcare, utilities and financials.
The BEL 20 continued to trade close to its record territory on Tuesday, November 10, as the Brussels benchmark stood at 6,130.41 points at 13:00:30 Berlin time. The index was up 32.32 points, or 0.53 percent, from Monday's close of 6,098.09. The calculation is based on the same BEL 20 index variant and the last completed Brussels session.
The latest quote showed an opening level of 6,122.61. The index traded between 6,111.98 and 6,141.13 during the session, with the day's high above the record level of 6,138.09 reported shortly after the opening by La Libre. That report said 16 index constituents were higher at the open, with Aperam gaining 1.55 percent and KBC rising 1.33 percent at that stage.
Momentum Builds After Monday Record
Monday's Brussels session had already pushed the benchmark to a new all-time high. Investing.com reported that the BEL 20 gained 1.70 percent at Monday's close, supported by healthcare, utilities and financials. Argenx was the strongest performer cited in that report, rising 4.66 percent to 853.80 euros, while KBC gained 2.77 percent and UCB advanced 2.72 percent.
For investors, Tuesday's midday reading indicates that the Belgian benchmark was consolidating close to its latest high rather than giving back the previous session's advance. The narrow gap between the opening level and the latest quote also points to a positive but more measured session after Monday's strong rise. The index remained sensitive to movements in its large healthcare, financial and materials constituents, as illustrated by the early performance of Aperam and KBC.
Further market developments and future BEL 20 reports are available on the BEL 20 topic page.
